Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis.
Boldrini L, Romano A, Chiloiro G, Corradini S, De Luca V, Verusio V, D'Aviero A, Castelluccia A, Alitto AR, Catucci F, Grimaldi G, Trapp C, Hörner-Rieber J, Marchesano D, Frascino V, Mattiucci GC, Valentini V, Gentile P, Gambacorta MA. Boldrini L, et al. Among authors: gentile p. Radiat Oncol. 2023 May 22;18(1):84. doi: 10.1186/s13014-023-02271-y. Radiat Oncol. 2023. PMID: 37218005 Free PMC article.
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO.
Mazzola R, Jereczek-Fossa BA, Antognoni P, Di Muzio N, Nicosia L, Lancia A, Fazio I, Chiesa S, Osti MF, Pergolizzi S, Franceschini D, Gentile P, Triggiani L, Alongi F. Mazzola R, et al. Among authors: gentile p. Med Oncol. 2021 Mar 24;38(5):48. doi: 10.1007/s12032-021-01493-y. Med Oncol. 2021. PMID: 33761017 Free article.
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G, Nardangeli A, Laliscia C, Fodor A, Draghini L, Gentile PC, D'Agostino GR, Balcet V, Bonome P, Ferioli M, Autorino R, Vicenzi L, Raguso A, Borghesi S, Ippolito E, Di Cataldo V, Cilla S, Perrucci E, Campitelli M, Gambacorta MA, Deodato F, Scambia G, Ferrandina G. Macchia G, et al. Among authors: gentile pc. Int J Gynecol Cancer. 2022 Jun 6;32(6):732-739. doi: 10.1136/ijgc-2021-003237. Int J Gynecol Cancer. 2022. PMID: 35193941
Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ, Clark MA, Özyar E, Kim M, Itami J, Tallet A, Debus J, Pfeffer R, Gentile P, Hama Y, Andratschke N, Riou O, Camilleri P, Belka C, Quivrin M, Kim B, Pedersen A, van Overeem Felter M, Kim YI, Kim JH, Fuss M, Valentini V. Slotman BJ, et al. Among authors: gentile p. Radiat Oncol. 2022 Aug 22;17(1):146. doi: 10.1186/s13014-022-02114-2. Radiat Oncol. 2022. PMID: 35996192 Free PMC article.
Stereotactic MR-guided adaptive radiotherapy (SMART) for primary rectal cancer: evaluation of early toxicity and pathological response.
Castelluccia A, Marchesano D, Grimaldi G, Annessi I, Bianciardi F, Borrazzo C, Dipalma A, El Gawhary R, Masi M, Rago M, Valentino M, Verna L, Portaluri M, Gentile P. Castelluccia A, et al. Among authors: gentile p. Rep Pract Oncol Radiother. 2023 Aug 28;28(4):437-444. doi: 10.5603/RPOR.a2023.0051. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 37795221 Free PMC article.
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.
Macchia G, Cilla S, Pezzulla D, Campitelli M, Laliscia C, Lazzari R, Draghini L, Fodor A, D'Agostino GR, Russo D, Balcet V, Ferioli M, Vicenzi L, Raguso A, Di Cataldo V, Perrucci E, Borghesi S, Ippolito E, Gentile P, De Sanctis V, Titone F, Delle Curti CT, Huscher A, Gambacorta MA, Ferrandina G, Morganti AG, Deodato F. Macchia G, et al. Among authors: gentile p. Gynecol Oncol. 2024 Jan 24;184:16-23. doi: 10.1016/j.ygyno.2024.01.023. Online ahead of print. Gynecol Oncol. 2024. PMID: 38271773
456 results